Results
|
241.
|
|
|
242.
|
|
|
243.
|
PCSK9 inhibitors in clinical practice: Novel directions and new experiences. [electronic resource] by
- Rallidis, Loukianos S
- Skoumas, Ioannis
- Liberopoulos, Evangelos N
- Vlachopoulos, Charalambos
- Kiouri, Estela
- Koutagiar, Iosif
- Anastasiou, Georgia
- Kosmas, Nikolaos
- Elisaf, Moses S
- Tousoulis, Dimitrios
- Iliodromitis, Efstathios
Producer: 20210818
In:
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 61
Availability: No items available.
|
|
244.
|
|
|
245.
|
|
|
246.
|
|
|
247.
|
|
|
248.
|
Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9. [electronic resource] by
- Edmiston, Jonathan B
- Brooks, Nathan
- Tavori, Hagai
- Minnier, Jessica
- Duell, Bart
- Purnell, Jonathan Q
- Kaufman, Tina
- Wojcik, Cezary
- Voros, Szilard
- Fazio, Sergio
- Shapiro, Michael D
Producer: 20171226
In:
Journal of clinical lipidology vol. 11
Availability: No items available.
|
|
249.
|
|
|
250.
|
The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption. [electronic resource] by
- Silbernagel, Günther
- Steiner, Lars K
- Hollstein, Tim
- Fauler, Günter
- Scharnagl, Hubert
- Stojakovic, Tatjana
- Schumann, Friederike
- Bölükbasi, Bediha
- März, Winfried
- Steinhagen-Thiessen, Elisabeth
- Laufs, Ulrich
- Kassner, Ursula
Producer: 20200210
In:
Journal of lipid research vol. 60
Availability: No items available.
|
|
251.
|
|
|
252.
|
|
|
253.
|
|
|
254.
|
|
|
255.
|
|
|
256.
|
|
|
257.
|
Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis. [electronic resource] by
- Paquette, Martine
- Gauthier, Dany
- Chamberland, Ann
- Prat, Annik
- De Lucia Rolfe, Emanuella
- Rasmussen, Jon J
- Kaduka, Lydia
- Seidah, Nabil G
- Bernard, Sophie
- Christensen, Dirk L
- Baass, Alexis
Producer: 20200402
In:
Clinical biochemistry vol. 77
Availability: No items available.
|
|
258.
|
|
|
259.
|
|
|
260.
|
|